Risk of adverse events in patients with bullous pemphigoid treated with oral corticosteroids in the...
Risk of adverse events in patients with bullous pemphigoid treated with oral corticosteroids in the United States
About this item
Full title
Author / Creator
Publisher
Wiley
Journal title
Language
English
Formats
Publication information
Publisher
Wiley
Subjects
More information
Scope and Contents
Contents
Background
The potential association of long‐term oral corticosteroid (OCS) use with adverse events (AEs) in patients with bullous pemphigoid (BP) is not well characterized in a real‐world setting.
Objectives
To evaluate the effect of OCS use and treatment duration on the incident AEs in patients with BP.
Methods
This retrospective c...
Alternative Titles
Full title
Risk of adverse events in patients with bullous pemphigoid treated with oral corticosteroids in the United States
Authors, Artists and Contributors
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_doaj_primary_oai_doaj_org_article_16ee0fb30da34575b66759ff2cd9c7a3
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_16ee0fb30da34575b66759ff2cd9c7a3
Other Identifiers
ISSN
2768-6566
E-ISSN
2768-6566
DOI
10.1002/jvc2.444
